Progenics Pharmaceuticals Inc

Ocular Therapeutix, Inc., based in Bedford, MA, is a pioneering company specializing in ophthalmology, particularly in the development of innovative therapies for retinal diseases. With a strong focus on redefining treatment and improving long-term visual outcomes, the company leverages its expertise to enhance clinical trial design and execution. The firm is recognized for its versatile ELUTYX technology platform, which creates sustained release therapies aimed at expanding treatment options across various ocular conditions. Ocular Therapeutix is rapidly growing and offers exciting career opportunities, emphasizing a culture of diversity, equity, and inclusion within its workforce. Generated from the website

Blue Oak Pharmaceuticals Inc is a pioneering biopharmaceutical company based in Concord, MA, dedicated to revolutionizing the treatment of brain disorders. With a focus on developing first-in-class and best-in-class drugs, their breakthrough approach challenges the traditional target-based methods used by the industry, offering new hope to millions of patients and their families who suffer from mental illness. By utilizing an unbiased approach to systems neuroscience and leveraging their privileged chemistry platform, Blue Oak is able to examine the entire brain circuitry and identify drug-like compounds with high efficiency. Their innovative use of predictive AI design, in collaboration with partners Exscientia and PsychoGenics, optimizes small molecules to normalize the behavioral symptoms of brain disorders. With a robust pipeline of clinical programs targeting bipolar depression, treatment-resistant depression, schizophrenia, and geriatric psychosis, Blue Oak is at the forefront of transforming the CNS drug discovery paradigm.Generated from the website

Founded in 1997, Takeda America Holdings offers various cash management and investment services. Located in New York City, Takeda America Holdings is a wholly owned subsidiary of Takeda Pharmaceutical Company, which discovers, develops, manufactures and markets a broad range of pharmaceutical products. Takeda Pharmaceutical Company sells its products in more than 100 countries under various brands names, including Lupron Depot, Enantone, Prostap and Leuplin, Prevacid, Ogast, Takepron, Blopress, Kenzen and Amias. Its research and development team works with other pharmaceutical manufacturers, biotechnology companies, universities and research institutions to promote medical drugs. The company also operates facilities in France, Germany, Austria, Ireland, China, Taiwan, Indonesia and Thailand.